Carnexiv™ (carbamazepine) – New orphan drug approval
October 7, 2016 – Lundbeck announced the FDA approval of Carnexiv (carbamazepine) injection as replacement therapy for oral carbamazepine formulations, when oral administration is temporarily not feasible, in adults with partial seizures with complex symptomatology, generalized tonic-clonic seizures or mixed seizure patterns or other partial or generalized seizures.
Top